Ozempic will likely get cheaper for millions on Medicare, Novo Nordisk exec says

Twitter

In This Story NVO LLY Ozempic, the blockbuster diabetes treatment by Novo Nordisk ( NVO ), is ‘very likely’ to see its price cut as part of the second round of Medicare drug price negotiation in 2025, an executive from the Danish pharma giant said on Tuesday. Suggested Reading 5 new details from inside Elon Musk's Twitter takeover Bernie Sanders says drugmakers could sell generic Ozempic for less than $100 Amazon's next Prime Day is coming fast Nvidia isn't the top stock anymore. A strategist

Tag-uri: Twitter

din zilele anterioare